Elective lateral neck dissection for laryngeal cancer in the clinically negative neck
- PMID: 16615158
- DOI: 10.1002/jso.20478
Elective lateral neck dissection for laryngeal cancer in the clinically negative neck
Abstract
Background: Despite the introduction of modern imaging techniques, it is still difficult to detect microscopic disease in neck nodes. The purpose of this study is to evaluate the efficacy of the lateral neck dissection (LND) for elective treatment of the clinically node negative neck (cN0) in laryngeal squamous cell carcinoma (SCC).
Methods: The clinical records of 110 cN0 patients with laryngeal SCC treated in this hospital from January 1997 to December 2002 were reviewed retrospectively.
Results: One hundred ten patients received 145 elective LND. Occult metastasis was detected in 22 (20.0%) of this group of patients. The distribution of the 37 positive nodes was as follows: Level II 56.8%; Level III 37.8%; Level IV 5.4%. The 3-year neck recurrence rate estimated by the Kaplan-Meier approach for all cN0 patients (n = 110) was 5.4% [95% CI: 0.0%; 12.5%]. No significant difference in 3-year lymph node recurrence was found between node negative and node positive groups, between supraglottis and glottis groups, or between surgery alone and combined therapy groups.
Conclusion: The lateral neck dissection is effective in elective treatment of the neck in patients with laryngeal carcinoma.
Copyright 2006 Wiley-Liss, Inc.
Similar articles
-
Is dissection of level IV absolutely necessary in elective lateral neck dissection for clinically N0 laryngeal carcinoma?Oral Oncol. 2006 Jan;42(1):102-7. doi: 10.1016/j.oraloncology.2005.06.019. Epub 2005 Sep 6. Oral Oncol. 2006. PMID: 16143563
-
[Neck relapse-related factors of cN0 stage supraglottic cancer].Ai Zheng. 2006 Mar;25(3):355-8. Ai Zheng. 2006. PMID: 16536994 Chinese.
-
Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer.Laryngoscope. 2006 Oct;116(10):1864-6. doi: 10.1097/01.mlg.0000234917.08822.cd. Laryngoscope. 2006. PMID: 17003711
-
Selective neck dissection (IIA, III): a rational replacement for complete functional neck dissection in patients with N0 supraglottic and glottic squamous carcinoma.Laryngoscope. 2008 Apr;118(4):676-9. doi: 10.1097/MLG.0b013e31815f6f25. Laryngoscope. 2008. PMID: 18182969 Review.
-
[Prophylactic postoperative radiotherapy in the treatment of supraglottic tumors].Acta Otorhinolaryngol Ital. 2000 Dec;20(6):432-41. Acta Otorhinolaryngol Ital. 2000. PMID: 11398681 Review. Italian.
Cited by
-
Incidence of Occult Lymph Node Metastasis in Primary Larynx Squamous Cell Carcinoma, by Subsite, T Classification and Neck Level: A Systematic Review.Cancers (Basel). 2020 Apr 24;12(4):1059. doi: 10.3390/cancers12041059. Cancers (Basel). 2020. PMID: 32344717 Free PMC article. Review.
-
Factors contributing to lymph node occult metastasis in supraglottic laryngeal carcinoma cT2-T4 N0M0 and metastasis predictive equation.Chin J Cancer Res. 2014 Dec;26(6):685-91. doi: 10.3978/j.issn.1000-9604.2014.12.06. Chin J Cancer Res. 2014. PMID: 25561766 Free PMC article.
-
Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.Clin Exp Otorhinolaryngol. 2017 Mar;10(1):1-43. doi: 10.21053/ceo.2016.01389. Epub 2017 Jan 3. Clin Exp Otorhinolaryngol. 2017. PMID: 28043099 Free PMC article.
-
Guidelines for the Treatment of Laryngeal Cancer from the Korean Society of Head and Neck Surgery.Clin Exp Otorhinolaryngol. 2025 May;18(2):89-108. doi: 10.21053/ceo.2025.00009. Epub 2025 Apr 8. Clin Exp Otorhinolaryngol. 2025. PMID: 40199514 Free PMC article.
-
Surgical nodal management in hypopharyngeal and laryngeal cancer.Eur Arch Otorhinolaryngol. 2020 May;277(5):1481-1489. doi: 10.1007/s00405-020-05838-7. Epub 2020 Feb 11. Eur Arch Otorhinolaryngol. 2020. PMID: 32048029 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials